Ly6G+ granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis.
Saved in:
| Title: | Ly6G+ granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis. |
|---|---|
| Authors: | Sharma P; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Sharma RD; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Sarkar B; National Institute of Immunology, New Delhi, India., Panwar V; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Das M; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Singh LV; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Jain N; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Chaturvedi S; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Mehra L; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India., Rathee A; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Sharma S; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Foo S; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Lee A; Infectious Diseases Labs (ID labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., N PK; Department of Immunology, ICMR-National Institute for Research in Tuberculosis, Chennai, India., Das P; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India., Viswanathan V; Prof. M. Viswanathan Diabetes Research Center, Chennai, India., Kornfeld H; Department of Medicine, University of Massachusetts Medical School, Worcester, United States., Howland SW; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Babu S; NIH-International Center of Excellence in Research, Chennai, India.; Laboratory of Parasitic Diseases, NIAID-NIH, Bethesda, United States., Nandicoori VK; National Institute of Immunology, New Delhi, India.; Centre for Cellular and Molecular Biology, Hyderabad, India., Singhal A; Infectious Diseases Labs (ID labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore, Singapore., Kumar D; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India. |
| Source: | ELife [Elife] 2026 Feb 05; Vol. 13. Date of Electronic Publication: 2026 Feb 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41642724 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ly6G<superscript>+</superscript> granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sharma+P%22">Sharma P</searchLink>; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Sharma+RD%22">Sharma RD</searchLink>; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Sarkar+B%22">Sarkar B</searchLink>; National Institute of Immunology, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Panwar+V%22">Panwar V</searchLink>; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Das+M%22">Das M</searchLink>; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Singh+LV%22">Singh LV</searchLink>; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Jain+N%22">Jain N</searchLink>; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Chaturvedi+S%22">Chaturvedi S</searchLink>; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Mehra+L%22">Mehra L</searchLink>; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Rathee+A%22">Rathee A</searchLink>; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Sharma+S%22">Sharma S</searchLink>; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Foo+S%22">Foo S</searchLink>; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+A%22">Lee A</searchLink>; Infectious Diseases Labs (ID labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22N+PK%22">N PK</searchLink>; Department of Immunology, ICMR-National Institute for Research in Tuberculosis, Chennai, India.<br /><searchLink fieldCode="AU" term="%22Das+P%22">Das P</searchLink>; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Viswanathan+V%22">Viswanathan V</searchLink>; Prof. M. Viswanathan Diabetes Research Center, Chennai, India.<br /><searchLink fieldCode="AU" term="%22Kornfeld+H%22">Kornfeld H</searchLink>; Department of Medicine, University of Massachusetts Medical School, Worcester, United States.<br /><searchLink fieldCode="AU" term="%22Howland+SW%22">Howland SW</searchLink>; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Babu+S%22">Babu S</searchLink>; NIH-International Center of Excellence in Research, Chennai, India.; Laboratory of Parasitic Diseases, NIAID-NIH, Bethesda, United States.<br /><searchLink fieldCode="AU" term="%22Nandicoori+VK%22">Nandicoori VK</searchLink>; National Institute of Immunology, New Delhi, India.; Centre for Cellular and Molecular Biology, Hyderabad, India.<br /><searchLink fieldCode="AU" term="%22Singhal+A%22">Singhal A</searchLink>; Infectious Diseases Labs (ID labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Kumar+D%22">Kumar D</searchLink>; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101579614%22">ELife</searchLink> [Elife] 2026 Feb 05; Vol. 13. <i>Date of Electronic Publication: </i>2026 Feb 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22eLife+Sciences+Publications%2C+Ltd%22">eLife Sciences Publications, Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579614 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-084X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222050084X%22">2050084X </searchLink><i>NLM ISO Abbreviation: </i>Elife <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41642724 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7554/eLife.100966 Languages: – Code: eng Text: English Titles: – TitleFull: Ly6G+ granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sharma P – PersonEntity: Name: NameFull: Sharma RD – PersonEntity: Name: NameFull: Sarkar B – PersonEntity: Name: NameFull: Panwar V – PersonEntity: Name: NameFull: Das M – PersonEntity: Name: NameFull: Singh LV – PersonEntity: Name: NameFull: Jain N – PersonEntity: Name: NameFull: Chaturvedi S – PersonEntity: Name: NameFull: Mehra L – PersonEntity: Name: NameFull: Rathee A – PersonEntity: Name: NameFull: Sharma S – PersonEntity: Name: NameFull: Foo S – PersonEntity: Name: NameFull: Lee A – PersonEntity: Name: NameFull: N PK – PersonEntity: Name: NameFull: Das P – PersonEntity: Name: NameFull: Viswanathan V – PersonEntity: Name: NameFull: Kornfeld H – PersonEntity: Name: NameFull: Howland SW – PersonEntity: Name: NameFull: Babu S – PersonEntity: Name: NameFull: Nandicoori VK – PersonEntity: Name: NameFull: Singhal A – PersonEntity: Name: NameFull: Kumar D IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 02 Text: 2026 Feb 05 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2050-084X Numbering: – Type: volume Value: 13 Titles: – TitleFull: ELife Type: main |
| ResultId | 1 |
